CELH
Overvalued by 104.3% based on the discounted cash flow analysis.
Market cap | $17.18 Billion |
---|---|
Enterprise Value | $16.43 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $0.77 |
Beta | 1.45 |
Outstanding Shares | 231,006,000 |
Avg 30 Day Volume | 3,656,033 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 94.41 |
---|---|
PEG | -39.53 |
Price to Sales | 14.88 |
Price to Book Ratio | 74.38 |
Enterprise Value to Revenue | 12.46 |
Enterprise Value to EBIT | 61.67 |
Enterprise Value to Net Income | 90 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
Celsius Holdings, Inc., is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CEL...